The Role of the Virology Laboratory in the Management of Hepatitis C Virus Infection

Overview

Journal J Clin Virol

Specialty Microbiology

Date 2002 Jul 20

PMID 12126716

Citations 3

Authors

William L Irving

Affiliations

Soon will be listed here.

Citing Articles

Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection.

Krajden M, Shivji R, Gunadasa K, Mak A, McNabb G, Friesenhahn M J Clin Microbiol. 2004; 42(9):4054-9.

PMID: 15364989 PMC: 516310. DOI: 10.1128/JCM.42.9.4054-4059.2004.

Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum.

Lefrere J, Roudot-Thoraval F, Lunel F, Alain S, Chaix M, Dussaix E J Clin Microbiol. 2004; 42(5):2027-30.

PMID: 15131165 PMC: 404593. DOI: 10.1128/JCM.42.5.2027-2030.2004.

Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA.

Hendricks D, Friesenhahn M, Tanimoto L, Goergen B, Dodge D, Comanor L J Clin Microbiol. 2003; 41(2):651-6.

PMID: 12574262 PMC: 149721. DOI: 10.1128/JCM.41.2.651-656.2003.

References

Pas S, Fries E, de Man R, Osterhaus A, Niesters H . Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol. 2000; 38(8):2897-901. PMC: 87141. DOI: 10.1128/JCM.38.8.2897-2901.2000. View

Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A . An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang. 2001; 80(1):63-71. DOI: 10.1046/j.1423-0410.2001.00003.x. View

van Esser J, van der Holt B, Meijer E, Niesters H, Trenschel R, Thijsen S . Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. Blood. 2001; 98(4):972-8. DOI: 10.1182/blood.v98.4.972. View

Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, de Groot T, Boucher C . Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol. 1999; 37(7):2291-6. PMC: 85140. DOI: 10.1128/JCM.37.7.2291-2296.1999. View

Niesters H, van ESSER J, Fries E, Wolthers K, Cornelissen J, Osterhaus A . Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol. 2000; 38(2):712-5. PMC: 86184. DOI: 10.1128/JCM.38.2.712-715.2000. View

van den Hoogen B, de Jong J, Groen J, Kuiken T, de Groot R, Fouchier R . A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001; 7(6):719-24. PMC: 7095854. DOI: 10.1038/89098. View

Niesters H . Quantitation of viral load using real-time amplification techniques. Methods. 2002; 25(4):419-29. DOI: 10.1006/meth.2001.1264. View

van Esser J, Niesters H, van der Holt B, Meijer E, Osterhaus A, Gratama J . Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood. 2002; 99(12):4364-9. DOI: 10.1182/blood.v99.12.4364. View

Schuurman R, Descamps D, Weverling G, Kaye S, Tijnagel J, Williams I . Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 1996; 34(12):3016-22. PMC: 229452. DOI: 10.1128/jcm.34.12.3016-3022.1996. View

10.

Mackay I, Arden K, Nitsche A . Real-time PCR in virology. Nucleic Acids Res. 2002; 30(6):1292-305. PMC: 101343. DOI: 10.1093/nar/30.6.1292. View

11.

Honkoop P, Niesters H, de Man R, Osterhaus A, Schalm S . Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. J Hepatol. 1997; 26(6):1393-5. DOI: 10.1016/s0168-8278(97)80476-x. View

12.

Honkoop P, de Man R, Heijtink R, Schalm S . Hepatitis B reactivation after lamivudine. Lancet. 1995; 346(8983):1156-7. DOI: 10.1016/s0140-6736(95)91829-9. View

13.

Damen M, Cuypers H, Zaaijer H, Reesink H, Schaasberg W, Gerlich W . International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods. 1996; 58(1-2):175-85. DOI: 10.1016/0166-0934(96)02011-3. View

14.

van Esser J, Niesters H, Thijsen S, Meijer E, Osterhaus A, Wolthers K . Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol. 2001; 113(3):814-21. DOI: 10.1046/j.1365-2141.2001.02789.x. View

15.

Niesters H, de Man R, Pas S, Fries E, Osterhaus A . Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy. J Med Microbiol. 2002; 51(8):695-699. DOI: 10.1099/0022-1317-51-8-695. View

16.

Stuyver L, Wyseur A, Rombout A, Louwagie J, Scarcez T, Verhofstede C . Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother. 1997; 41(2):284-91. PMC: 163703. DOI: 10.1128/AAC.41.2.284. View

17.

Valentine-Thon E, van Loon A, Schirm J, Reid J, Klapper P, Cleator G . European proficiency testing program for molecular detection and quantitation of hepatitis B virus DNA. J Clin Microbiol. 2001; 39(12):4407-12. PMC: 88557. DOI: 10.1128/JCM.39.12.4407-4412.2001. View

18.

Quint W, Heijtink R, Schirm J, Gerlich W, Niesters H . Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol. 1995; 33(1):225-8. PMC: 227915. DOI: 10.1128/jcm.33.1.225-228.1995. View

19.

Allen M, Gauthier J, Deslauriers M, BOURNE E, Carrick K, Baldanti F . Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine. J Clin Microbiol. 1999; 37(10):3338-47. PMC: 85560. DOI: 10.1128/JCM.37.10.3338-3347.1999. View

20.

. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol. 2000; 31 Suppl 1:3-8. View